title: Demographic and prognostic factors of 455 patients with acute leukemia admitted to two referral hospitals in tehran-iran during ten years (2001-2011).
abstract: BACKGROUND
  Global death toll of Acute Leukemia (AL), as a heterogeneous group of hematopoietic malignancies, is rather high, i.e. almost 74% of 300,000 new cases die every year. This reflects a poor prognosis of this malignancy in most parts of the world, where contemporary and rather complex remedies are not available. There are a few well documented reports about the epidemiologic features of AL at national level in Iran. This retrospective study demonstrates demographic and laboratory features of Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) patients admitted to the main referral oncology hospitals in the ex-Iran University of Medical Sciences in Tehran (Firoozgar and Rasoul-Akram hospitals) during the last decade (2001-2011).
  
  
  METHODS
  Medical records of all patients admitted to the both hospitals diagnosed with AML and ALL were reviewed during the study period for demographic, biological and clinical characteristics at diagnosis.
  
  
  RESULTS
  Four-hundred fifty five patients were diagnosed with AML and ALL, who admitted to the both hospitals during ten years, of whom 59.6 % (271 patients) were male. Fifty five percent of patients had AML and 44.6 % had ALL, both significantly dominated in men (p<0.001). AML patients died more significantly (p<0.05) and the most deaths occurred in older patients (p<0.001). Initial WBC count was significantly related to death (p= 0.001), where the least death (13%) occurred in the group with initial WBC between 5-10×10(3)/μL and most of deceased had an initial WBC more than 10×10(3)/μL. Logistic regression showed that age, fever and WBC were significant prognostic factors.
  
  
  CONCLUSIONS
  Demographic characteristics of AL patients were almost the same as other global reports. Most deaths occurred in older patients, those who had fever, and patients with higher WBC count at first admission, which warrants more investigations accurately and also improvements in hospital records.
authors: Dept. of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
authors: Parvin
authors: P
authors: Ayremlou
authors: Oncopathology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
authors: Seyed Mohsen
authors: SM
authors: Razavi
authors: Dept. of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
authors: Masoud
authors: M
authors: Solaymani-Dodaran
authors: Oncopathology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
authors: Masoud
authors: M
authors: Vakili
authors: Dept. of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran ; Oncopathology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
authors: Mohsen
authors: M
authors: Asadi-Lari
keywords: Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Epidemiology; Iran
references: Intern Med. 2009;48(18):1629-33
references: 19755765
references: Oncologist. 2009 Mar;14(3):222-32
references: 19282349
references: Ann Oncol. 2005 Aug;16(8):1366-73
references: 15956039
references: J Clin Oncol. 2004 Oct 15;22(20):4075-86
references: 15353542
references: Haematologica. 2004 Mar;89(3):296-302
references: 15020267
references: Haematologica. 2011 Sep;96(9):1310-7
references: 21606167
references: Cancer. 2003 May 1;97(9):2229-35
references: 12712476
references: Arch Iran Med. 2009 Jan;12(1):15-23
references: 19111024
references: Haematologica. 2008 Dec;93(12):1806-13
references: 18838471
references: Blood. 2006 Jul 15;108(2):441-51
references: 16556894
references: Eur J Haematol. 2011 Jan;86(1):38-46
references: 21077959
references: Eur J Cancer. 2011 Jan;47(1):90-7
references: 20970323
references: Blood. 2002 Dec 1;100(12):3869-76
references: 12393614
references: J Clin Oncol. 1996 Jan;14(1):18-24
references: 8558195
references: Cancer. 2006 Nov 1;107(9):2099-107
references: 17019734
references: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references: 15761078
references: Indian J Pathol Microbiol. 2010 Oct-Dec;53(4):704-10
references: 21045397
references: Cancer. 2008 Jan 15;112(2):407-15
references: 18058809
references: J Pediatr. 2012 Jan;160(1):10-8
references: 21920540
references: Br J Haematol. 2009 Jun;145(5):598-605
references: 19344426
references: Cancer Treat Rev. 2004 Feb;30(1):37-51
references: 14766125
references: J Pediatr (Rio J). 2003 Mar-Apr;79(2):149-58
references: 14502336
references: Blood. 2002 Feb 1;99(3):863-71
references: 11806988
references: Cancer. 2005 Aug 1;104(3):547-54
references: 15973664
references: Haematologica. 2004 Sep;89(9):1082-90
references: 15377469
references: Leukemia. 2009 Dec;23(12):2275-80
references: 19741728
references: J Exp Clin Cancer Res. 2011 Apr 10;30:36
references: 21477348
references: Blood. 2012 Jan 5;119(1):34-43
references: 22086414
references: Cancer. 2008 Feb 1;112(3):562-71
references: 18076087
references: Eur J Haematol. 2002 Jan;68(1):54-63
references: 11952822
references: Int J Hematol. 2000 Jul;72(1):61-8
references: 10979211
references: JAMA. 2007 Mar 21;297(11):1207-15
references: 17374815
references: Leuk Res. 2004 Jan;28(1):43-8
references: 14630079
references: Leuk Lymphoma. 2008 Dec;49(12):2291-7
references: 19052976
references: Singapore Med J. 2011 May;52(5):370-4
references: 21633773
references: Leuk Res. 2003 Mar;27(3):205-14
references: 12537972
references: Cancer. 1998 Apr 1;82(7):1387-95
references: 9529033
references: Leuk Res. 2011 Mar;35(3):334-9
references: 20828817
references: Eur J Cancer. 2010 Dec;46(18):3280-6
references: 20674335
references: Haematologica. 2008 Jul;93(7):1025-32
references: 18508801
references: Leuk Lymphoma. 2008 Jun;49(6):1142-54
references: 18569638
references: Asian Pac J Cancer Prev. 2004 Apr-Jun;5(2):188-9
references: 15244523
references: J Crit Care. 2004 Mar;19(1):29-35
references: 15101003
references: Med Oncol. 2010 Dec;27(4):1254-9
references: 19937404
references: Leukemia. 2002 Apr;16(4):601-7
references: 11960339
references: Leuk Res. 2007 Jul;31(7):907-14
references: 17005250
references: Eur J Cancer. 2009 Feb;45(3):420-7
references: 19004628
references: Exp Hematol. 2009 Jun;37(6):649-58
references: 19463767
references: J Exp Clin Cancer Res. 2008 Nov 23;27:74
references: 19025609
references: Drugs Aging. 2005;22(11):943-55
references: 16323971